European stocks stabilise after tech-driven rout By Reuters
(Reuters) – European stocks steadied on Wednesday after one of the worst market routs this year, with investors turning to defensive healthcare stocks amid lingering concerns about growth and inflation.
The pan-European index rose 0.8% after shedding 2.2% on Tuesday in their biggest percentage daily decline since mid-July.
The global stock market fell due to widespread fear-off sentiment. Government bond yields rose on rising expectations of higher interest rate increases and diverted investors from high-growth tech stocks.
The European technology sector was under pressure and only 0.5% gained after a loss of 4.8% Tuesday.
ASML Holding (NASDAQ 🙂 NV, a key supplier to chipmakers, fell 1% despite meeting financial goals.
U.S. chipmaker Micron Technology warned that its memory chip shipments would drop overnight as customers who make personal computers are facing shortages of parts.
AstraZeneca, a British pharmaceutical company (NASDAQ:), gained 2.3% following the announcement that its Alexion (NASDAQ;) division would purchase all equity remaining in Caelum Biosciences. This deal could potentially be worth as much as $500 million.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.